Evidence map›Paper›PMID 34572573›Full record

ReviewBiomolecules2021

TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain.

Anja Schlecht, Mario Vallon, Nicole Wagner, Süleyman Ergün, Barbara M Braunger

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anja SchlechtInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.
Mario VallonInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.
Nicole WagnerInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.
Süleyman ErgünInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.
Barbara M BraungerInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, D-97070 Wuerzburg, Germany.
University of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic insults to the heart and brain, i.e., myocardial and cerebral infarction, respectively, are amongst the leading causes of death worldwide. While there are therapeutic options to allow reperfusion of ischemic myocardial and brain tissue by reopening obstructed vessels, mitigating primary tissue damage, post-infarction inflammation and tissue remodeling can lead to secondary tissue damage. Similarly, ischemia in retinal tissue is the driving force in the progression of neovascular eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), which eventually lead to functional blindness, if left untreated. Intriguingly, the easily observable retinal blood vessels can be used as a window to the heart and brain to allow judgement of microvascular damages in diseases such as diabetes or hypertension. The complex neuronal and endocrine interactions between heart, retina and brain have also been appreciated in myocardial infarction, ischemic stroke, and retinal diseases. To describe the intimate relationship between the individual tissues, we use the terms heart-brain and brain-retina axis in this review and focus on the role of transforming growth factor β (TGFβ) and neurotrophins in regulation of these axes under physiologic and pathologic conditions. Moreover, we particularly discuss their roles in inflammation and repair following ischemic/neovascular insults. As there is evidence that TGFβ signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is discussed here, that cross-talk between TGFβ and neurotrophin signaling protects cells from harmful and/or damaging events in the heart, retina, and brain.

Indexed as

AnimalsBrainHumansMyocardiumNerve Growth FactorsProtein BindingRetinaTransforming Growth Factor betaNerve Growth FactorsTransforming Growth Factor betaage-related macular degenerationbrain-retina axisdiabetic retinopathyheart-brain axisischemic strokemyocardial infarctionneurotrophinsTGFβ signaling

Identifiers

PMID34572573
PMCPMC8464756
OpenAlexW3200245244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.